Citation: R. Hjertberg et al., BLOOD-PRESSURE MONITORING IN WOMEN WITH PREVIOUS DIAGNOSIS OF PREECLAMPSIA - THE INFLUENCE OF THE MENSTRUAL-CYCLE, Hypertension in pregnancy, 17(3), 1998, pp. 251-263
Citation: S. He et al., FIBRIN D-DIMER LEVELS IN PREECLAMPTIC PREGNANCIES WITH BIRTH OF SMALL-FOR-GESTATIONAL-AGE NEONATES, Hypertension in pregnancy, 17(2), 1998, pp. 217-226
Authors:
BLOMBACK M
BREMME K
HELLGREN M
LINDBERG H
Citation: M. Blomback et al., A PHARMACOKINETIC STUDY OF DALTEPARIN (FRAGMIN(R)) DURING LATE PREGNANCY, Blood coagulation & fibrinolysis, 9(4), 1998, pp. 343-350
Authors:
BLOMBACK M
BREMME K
HELLGREN M
SIEGBAHN A
LINDBERG H
Citation: M. Blomback et al., THROMBOPROPHYLAXIS WITH LOW-MOLECULAR-MASS HEPARIN, FRAGMIN (DALTEPARIN), DURING PREGNANCY - A LONGITUDINAL SAFETY STUDY, Blood coagulation & fibrinolysis, 9(1), 1998, pp. 1-9
Citation: Mi. Bokarewa et K. Bremme, PRODUCTION OF PHOSPHOLIPID ANTIBODIES IN SELECTED THROMBOPHILIC WOMENDIFFERING IN GENOTYPE AT THE 506 SITE OF FACTOR-V, European journal of haematology, 61(1), 1998, pp. 21-26
Citation: E. Ostlund et al., SOLUBLE FIBRIN IN PLASMA AS A SIGN OF ACTIVATED COAGULATION IN PATIENTS WITH PREGNANCY COMPLICATIONS, Acta obstetricia et gynecologica Scandinavica, 77(2), 1998, pp. 165-169
Citation: S. He et al., ACQUIRED DEFICIENCY OF ANTITHROMBIN IN ASSOCIATION WITH A HYPERCOAGULABLE STATE AND IMPAIRED FUNCTION OF LIVER AND OR KIDNEY IN PREECLAMPSIA/, Blood coagulation & fibrinolysis, 8(4), 1997, pp. 232-238
Authors:
BOKAREWA MI
WRAMSBY M
BREMME K
BLOMBACK M
Citation: Mi. Bokarewa et al., VARIABILITY OF THE RESPONSE TO ACTIVATED PROTEIN-C DURING NORMAL-PREGNANCY, Blood coagulation & fibrinolysis, 8(4), 1997, pp. 239-244
Authors:
BOKAREWA MI
WRAMSBY M
MEHRKASH M
BREMME K
BLOMBACK M
Citation: Mi. Bokarewa et al., THE IMPACT OF FACTOR-VIII IN THE FLUCTUATION OF APC RESPONSE IN HEALTHY PREGNANT-WOMEN, Thrombosis and haemostasis, 1997, pp. 1303-1303
Citation: S. He et al., ACQUIRED DEFICIENCY OF ANTITHROMBIN ASSOCIATED WITH A HYPERCOAGULABLESTATE AND DAMAGE OF LIVER AND KIDNEY IN PREECLAMPSIA, Thrombosis and haemostasis, 1997, pp. 1774-1774
Citation: Mi. Bokarewa et al., PRODUCTION OF PHOSPHOLIPID ANTIBODIES (PLA) BY THE CARRIERS AND NONCARRIERS OF THE ARG506-GLN MUTATION IN FACTOR-V, Thrombosis and haemostasis, 1997, pp. 2183-2183
Citation: K. Bremme et al., APC RESISTANCE AND ITS RELATION TO THROMBOTIC INCIDENCE DURING PREGNANCY AND PUERPERIUM, Thrombosis and haemostasis, 1997, pp. 2979-2979
Authors:
ANDERSSON O
BLOMBACK M
BREMME K
WRAMSBY H
Citation: O. Andersson et al., PREDICTION OF CHANGES IN LEVELS OF HEMOSTATIC VARIABLES DURING NATURAL MENSTRUAL-CYCLE AND OVARIAN HYPERSTIMULATION, Thrombosis and haemostasis, 77(5), 1997, pp. 901-904
Authors:
BOKAREWA MI
FALK G
BREMME K
BLOMBACK M
WIMAN B
Citation: Mi. Bokarewa et al., SEARCH FOR MUTATIONS IN THE GENES FOR COAGULATION-FACTOR-V AND COAGULATION-FACTOR-VIII WITH A POSSIBLE PREDISPOSITION TO ACTIVATED PROTEIN-C RESISTANCE, European journal of clinical investigation, 27(4), 1997, pp. 340-345
Authors:
TORNGREN S
HJERTBERG R
ROSFORS S
BREMME K
ERIKSSON M
SWEDENBORG J
Citation: S. Torngren et al., THE LONG-TERM OUTCOME OF PROXIMAL VEIN-THROMBOSIS DURING PREGNANCY ISNOT IMPROVED BY THE ADDITION OF SURGICAL THROMBECTOMY TO ANTICOAGULANT TREATMENT, European journal of vascular and endovascular surgery, 12(1), 1996, pp. 31-36
Citation: S. He et al., DECREASE IN PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 RELATED MORE TO PLACENTAL FUNCTION AND INTRAUTERINE FETAL GROWTH THAN TO SEVERITY OF PREECLAMPSIA, Hypertension in pregnancy, 15(2), 1996, pp. 171-182
Citation: K. Bremme et M. Blomback, HEMOSTATIC ABNORMALITIES MAY PREDICT CHRONIC HYPERTENSION AFTER PREECLAMPSIA, Gynecologic and obstetric investigation, 41(1), 1996, pp. 20-26
Citation: Mi. Bokarewa et al., ARG(506)-GLN MUTATION IN FACTOR-V AND RISK OF THROMBOSIS DURING PREGNANCY, British Journal of Haematology, 92(2), 1996, pp. 473-478
Citation: S. He et al., INCREASED BLOOD-FLOW RESISTANCE IN PLACENTAL CIRCULATION AND LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITORS TYPE-1 AND TYPE-2 IN SEVERE PREECLAMPSIA, Blood coagulation & fibrinolysis, 6(8), 1995, pp. 703-708
Citation: Mi. Bokarewa et al., PHOSPHOLIPID ANTIBODIES AND RESISTANCE TO ACTIVATED PROTEIN-C IN WOMEN WITH THROMBOPHILIA, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 417-422
Authors:
BUCHT E
RONG HQ
BREMME K
GRANBERG B
RIAN E
TORRING O
Citation: E. Bucht et al., MIDMOLECULAR PARATHYROID HORMONE-RELATED PEPTIDE IN SERUM DURING PREGNANCY, LACTATION AND IN UMBILICAL-CORD BLOOD, European journal of endocrinology, 132(4), 1995, pp. 438-443
Citation: S. He et al., INCREASED CONCENTRATIONS OF LACTATE-DEHYDROGENASE IN PREGNANCY WITH PREECLAMPSIA - A PREDICTOR FOR THE BIRTH OF SMALL-FOR-GESTATIONAL-AGE INFANTS, Gynecologic and obstetric investigation, 39(4), 1995, pp. 234-238
Authors:
BLOMBACK M
ANDERSSON O
BREMME K
WRAMSBY H
Citation: M. Blomback et al., A PRESENT LEVEL OF HEMOSTATIC VARIABLE MAY PREDICT WHAT HAPPENS UNDERHORMONAL INFLUENCE, Thrombosis and haemostasis, 73(6), 1995, pp. 1233-1233
Citation: S. He et al., PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN PREECLAMPSIA - DECREASES IN PAI-2 SUGGESTING PLACENTAL OR FETAL COMPLICATIONS AND FETUS ASSUMED TO BE ONE OF REGULATORS OF PAI-2 SYNTHESIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1302-1302